Feedback / Questions
MEDI0639 - AstraZeneca
AstraZeneca: H1 FY 2016 Results
(AstraZeneca)
-
Jul 30, 2016 -
Discontinuation in solid tumors due to safety/efficacy reason
Discontinued
•
Oncology
https://www.astrazeneca.com/content/dam/az/press-releases/2016/H1_2016_results_press_release.pdf
Jul 30, 2016
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious